Ado09, a co-formulation of pramlintide and insulin A21G, improves body weight and treatment satisfaction compared to insulin lispro in people with type 1 diabetes (PwT1D)

Tresiba (insulin degludec) - Novo Nordisk

pramlintide/insulin A21G (ADO09) - Adocia

R. Eloy1; M. Gaudier1; E. Baumgaertner2; C. Seroussi1; C. Mégret1; B. Kronshage3; Y.-P. Chan1; O. Soula1; T. Heise3; G. Andersen3

Jul 9, 2022